Caitlin May, PhD, postdoctoral research scientist at Eli Lilly and Company, discusses preclinical activity with olaratumab (Lynparza) in pediatric sarcoma models.
Caitlin May, PhD
Advertisement
Articles by Caitlin May, PhD
Advertisement
Latest Updated Articles
Preclinical Activity With Olaratumab in SarcomaJanuary 6th 2017
Advertisement
Advertisement
Trending on OncLive
1
FDA Finalizes 3 Guidance Documents to Broaden Cancer Clinical Trial Eligibility Criteria
2
Innovative Screening Approaches, Targeted Therapies, and Team-Based Care Drive Head and Neck Oncology Advances
3
AI Tools Show Early Promise Across Drug Discovery, Clinical Decision-Making in Lung Cancer
4
HR-Positive/HER2-Negative Metastatic Breast Cancer: Treatment Sequencing After Adjuvant Endocrine Therapy and Transitioning Beyond Endocrine-Based Approaches
5